Catalyst
Slingshot members are tracking this event:
Ocular Therapeutics (OCUL) set for July 19 PDUFA decision for lead product DEXTENZA, a treatment for post-op ocular pain following ophthalmic surgery
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| OCUL | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jul 11, 2017
Occurred Source:
http://investors.ocutx.com/phoenix.zhtml?c=253650&p=irol-newsArticle&ID=2285862
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Dextenza, Ocular Pain, Ophthalmic Surgery, Pdufa
